DRREDDY.BO

Dr. Reddy's Laboratories Limited

HealthcareDrug Manufacturers - Specialty & GenericININRCountry macro →

$1,276.40

Jun 02, 2026

Revenue · FY

$335.93B

Net income

$42.85B

FY 2026

EPS · diluted

$51.42

EBITDA

$67.05B

Explain this page

Arphra AIPlain-English read on Dr. Reddy's Laboratories Limited’s valuation

No corporate actions

No dividend or split records loaded for DRREDDY-IB.